Project description
Microfluidic-based cryopreservation of living cells and bio-samples
The increased demand for cell therapy products requires that the World Health Organisation issue new regulations for the clinical storage and applications of these developed products. An immediate need is to create research and infrastructure for the long-time storage of the products. Current processes such as cryopreservation, lyophilisation and desiccation are highly toxic for cell viability. The EU-funded MCRD project is proposing a collaboration with French company Eden Tech to develop a microfluidic-based cryo-ready device for plug-and-play type biological cell sample storage and testing. The novel product will pave the way for further advanced studies into physical biology.
Objective
Innovation in development of cell therapy products are growing rapidly. As per the report of WHO, in the year 2015, total 38 such innovation has been taken place in EU region and other developed countries. Such accelerated growth of the technology leads WHO to configure regulatory issues for the clinical storage and applications of these developed products. Thus, on the basis of current requirements, there is a immediate need to develop systemic research and infrastructure for storage of the developed biological products for longer duration of time. Cryopreservation, lyophilization, and desiccation are the major techniques been used for the preservation of biological products, namely different types of cells. But all above mentioned process are highly toxic while considering cellular viability. At the same time, this processes are bulky and involves substantial cost affair.
In current project proposal, ER in collaboration with Eden Microfluidics have proposed development of a microfluidic based cryo-ready device for plug-and-play type cell / biological sample storage, testing, and laboratory usage. The proposed technique is highly inter-disciplinary, and with the experience of ER and his mentors from Eden Microfluidics, they are confident for the development of the product. The development of the product will yield new insight of physical biology in the field of magneto-hydrodynamics, biological thermodynamics, and bio-microfluidics.
The proposed project is not only limited to the development of product, but it will extend the work for marketing and production of the product, and dissemination of the acquired field of science to the national and international universities as text contents (in form of book chapters), laboratory tutorials through the collaborations of ER. The developed cryo-ready microfluidic device will also foster ER for involve in EU region as a start-up, and thus contribute to the economical growth of the region directly.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences physical sciences classical mechanics fluid mechanics microfluidics
- natural sciences physical sciences thermodynamics
- medical and health sciences medical biotechnology cells technologies
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2018
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75015 Paris
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.